Preface to the Journal of Cardiovascular Disease Research, second issue 2012

I am delighted to present this issue of the Journal of Cardiovascular Disease Research (JCDR). The JCDR is proud to enter 2012 in a strong position. Readers may be aware that Wolters Kluwer Health (Philadelphia, PA) acquired Medknow and thus became the publisher of JCDR. Wolters Kluwer Health is a leading global provider of information and business intelligence for physicians, nurses, students and specialized clinicians. Major brands include Lippincott Williams & Wilkins, Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource® and ProVation® Medical. With new opportunities and challenges, we will continue to strive to make JCDR more influential, powerful and useful to the cardiovascular disease research community. The exponential growth and enhanced visibility of JCDR is reflected by the rapid rate of indexing in PubMed, PubMed Central, Scopus, Google Scholar, Chemical Abstracts, etc. This is paralleled by an increase in the number of article downloads, indicating that JCDR has been attracting more readers in the area of cardiovascular disease research. The number of submitted manuscripts from all over the world is also increasing steadily, demonstrating that our journal is becoming a respected and reliable venue for researchers to disseminate their findings.